Baxter Warning Letter Highlights Beta-La
Baxter International Inc, was issued an FDA Warning Letter following cGMP violations observed during an
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Baxter International Inc, was issued an FDA Warning Letter following cGMP violations observed during an
The U.S. FDA has issued a Warning Letter to Simtra BioPharma Solutions following cGMP deviations
The USFDA issued a Warning Letter to API manufacturer Chemspec Chemicals (Mumbai) in December 2025,
The USFDA has escalated the OAI (Official Action Indicated) classification of the Novo Nordisk–owned Catalent
Janssen Vaccines Corp., a Johnson & Johnson company operating in Korea, was issued an FDA
The USFDA issued a Warning letter to Amneal Pharmaceuticals following critical deviations observed during an
USFDA has issued a Warning letter to Glenmark Pharma’s Pithampur manufacturing facility (FEI 3008565058). The
The U.S. Food and Drug Administration (FDA) has issued a Warning Letter in June 2025
The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Aspen Biopharma Labs
The U.S. FDA issued a warning letter to International Laboratories Corp. (FEI 3006403166) following CGMP